LevelBlue Agrees to Acquire Aon’s Cybersecurity & IP Litigation Consulting Groups
LevelBlue, a global leader in cloud-based, AI-driven managed security services, has signed a definitive agreement to acquire Aon’s Cybersecurity and Intellectual Property (IP) Litigation consulting groups, which include recognized cybersecurity firm Stroz Friedberg, and Elysium Digital, which is renowned for technology-related IP litigation matters. This acquisition represents a significant step in LevelBlue’s growth strategy by adding deep cyber and high-tech IP litigation consulting expertise and world-class incident response capabilities to its expanding global portfolio. Financial terms were not disclosed and the acquisition is subject to customary closing conditions.
With this acquisition, LevelBlue gains a globally recognized cyber and IP litigation consulting platform that includes a team of approximately 300 technology professionals with strong relationships across Fortune 500 enterprises, 80 percent of the Am Law 100 and a majority of Top 20 law firms in the UK. The integration of consulting solutions complements LevelBlue’s 24/7 managed detection and response services, creating a comprehensive cybersecurity risk management offering that addresses both digital risk protection and incident response, positioning LevelBlue to become the largest independent pureplay Managed Security Services Provider (MSSP) globally.
“Cyber resilience is crucial for organizations of all sizes," said Robert McCullen, Chairman and CEO of LevelBlue. "By combining LevelBlue’s exceptional cloud-based, AI-driven managed detection and response platform with Stroz Friedberg’s proactive cyber consulting and advanced digital forensic and incident response capabilities, we’re introducing the industry’s most comprehensive unified cybersecurity services platform. This platform will not only strengthen clients’ defenses preemptively, but also empower them with deeper insights and faster incident resolution. Together, we’re helping organizations stay ahead of emerging threats and recover with greater speed and confidence.”
“We are thrilled to join forces with LevelBlue,” said David Yaches, CEO of Cyber Solutions Security Consulting at Aon. “Our teams are aligned in mission and values, and this acquisition will allow us to serve clients with an expanded suite of cyber solutions and deeper technical expertise.”
Aon’s Cybersecurity consulting group is also recognized as a clear leader in the 2024 Forrester Wave™ for Cybersecurity Incident Response Services by providing organizations with a comprehensive range of cyber resilience services designed to help them prepare for, withstand and recover from cyber incidents. Its cybersecurity risk management portfolio covers adversary simulation, penetration testing, incident response planning, real-time breach response, and digital forensics. With deep technical expertise and proven methodologies, Aon’s Cybersecurity and IP Litigation consulting groups assist clients in strengthening their operational readiness, protecting their critical digital assets, and minimizing the impact of cyber events and accelerating recovery times.
“The incredible cybersecurity readiness and response capabilities of Aon’s Cybersecurity consulting group, including the esteemed heritage of the Stroz Friedberg legacy, brings highly valued expertise to LevelBlue,” said Mike Troiano, LevelBlue Board Member and Head of AT&T Business Products. “We expect this acquisition to significantly enhance the strategic cybersecurity services delivered globally by LevelBlue to AT&T’s government and enterprise customers.”
As part of this transaction, Aon and LevelBlue will also establish a strategic relationship to collaboratively offer their respective services to clients in a holistic manner. This acquisition underscores LevelBlue’s commitment to simplifying cybersecurity through award-winning managed services, strategic consulting, real-time threat intelligence and industry-renowned research, seamlessly integrated with its global operations and operational expertise to deliver solutions that help organizations of all sizes achieve their unique cybersecurity outcomes.
“Cyber remains a top risk category for our clients,” said Christian Hoffman, Global Specialty & Financial Products Leader at Aon. “Aon will continue to deliver leading cyber brokerage capabilities through our Cyber Solutions group, CyQu platform and Cyber Risk Analyzer to serve our clients growing cyber broking needs.”
According to Christina Richmond, Principal Analyst at Richmond Advisory Group, “This is a highly strategic acquisition for the cybersecurity services market. LevelBlue will strengthen its position at the intersection of managed security and cyber consulting services. By acquiring leading cybersecurity and IP litigation consulting capabilities, the combined organization is now better positioned to proactively enhance organizational resilience. The strategic relationship with Aon bolsters LevelBlue’s posture with cyber insurers and adds highly complementary risk analysis and advisory services.”
Santander is serving as financial advisor and Kirkland & Ellis LLP is serving as legal advisor to LevelBlue. Lazard is serving as financial advisor and Latham & Watkins LLP is serving as legal advisor to Aon.
About LevelBlue
We simplify cybersecurity through award-winning managed services, experienced strategic consulting, threat intelligence, and renowned research. Our team is a seamless extension of yours, providing transparency and visibility into security posture and continuously working to strengthen it.
We harness security data from numerous sources and enrich it with artificial intelligence to deliver real-time threat intelligence; this enables more accurate and precise decision making. With a large, always-on global presence, LevelBlue sets the standard for cybersecurity today and tomorrow. We easily and effectively manage risk, so you can focus on your business.
About Aon
Aon plc (NYSE: AON) exists to shape decisions for the better — to protect and enrich the lives of people around the world. Through actionable analytic insight, globally integrated Risk Capital and Human Capital expertise, and locally relevant solutions, our colleagues provide clients in over 120 countries with the clarity and confidence to make better risk and people decisions that protect and grow their businesses.
Follow Aon on LinkedIn, X, Facebook and Instagram. Stay up-to-date by visiting Aon’s newsroom and sign up for news alerts here.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250611000446/en/
Contacts
Media Contact:
LevelBlue Media Contact
Jessica Bettencourt
Inkhouse for LevelBlue
levelblue@inkhouse.com
(774) 451-5142
Aon Media Contact
Will Dunn
mediainquiries@aon.com
+1 312 381 3024
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 Data for Incyte’s Retifanlimab (Zynyz ® ) in Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) Published in The Lancet13.6.2025 01:45:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced that primary results from the Phase 3 POD1UM-303/InterAACT 2 trial of retifanlimab (Zynyz®), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with carboplatin and paclitaxel (platinum-based chemotherapy) in adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal cancer (SCAC) who have not been previously treated with systemic chemotherapy, were published in The Lancet.1 “The publication of the POD1UM-303/InterAACT 2 trial in The Lancet is a testament to the strength of the data generated for retifanlimab in patients with inoperable locally recurrent or metastatic SCAC, a disease which until recently had seen limited innovation for decades,” said Steven Stein, M.D., Chief Medical Officer, Incyte. “SCAC can be a devastating disease, and patients often have a poor prognosis. These data supported the U.S. Food and Drug Administration (FDA) approval of Zynyz® (retifanl
Güntner Drives Group-Wide Innovation in 2024 Sustainability Report12.6.2025 22:30:00 EEST | Press release
Güntner, a global leader in refrigeration and heat exchange technology, today announced its featured role in the newly released 2024 A-HEAT Sustainability Report. The report outlines significant progress toward ambitious environmental goals—fueled by Güntner’s commitment to measurable, innovation-led sustainability. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612897493/en/ Güntner advances global sustainability goals with progress in natural refrigerants, water savings, and circular economy efforts. Working toward its 2030 sustainability targets, Güntner delivered significant achievements across key areas including natural refrigeration integration, water and energy efficiency and the development of circular economy solutions. These efforts reflect Güntner’s ongoing mission to make sustainability not just a goal, but a core driver of innovation. Key milestones include a near-complete transition to natural refrigerants
Windsurf Launches First GPU Cluster in Germany, Expanding Secure Enterprise AI in Europe12.6.2025 21:45:00 EEST | Press release
Windsurf, a leader in AI-powered software development, today announced its first GPU cluster in Germany, as product demand surges and the company expands performance capacity across the EU. With over 100 local enterprise customers already using Windsurf products, the new cluster marks the company’s first major international step in building scalable infrastructure for the European market. Located in Frankfurt, home to some of the world’s strictest data security laws, the cluster was a natural choice for Windsurf’s first deployment. This cluster was specifically designed to meet the unique security and performance requirements of European enterprises, providing a framework for high performance in even the most complex, secure environments. “With about 6 million developers across Europe, users deserve infrastructure that meets them where they are,” said Varun Mohan, CEO of Windsurf. “The demand for secure AI-powered development is undeniable and by launching this GPU cluster, we aim to b
Xsolla Partners With Defold to Enable Seamless In-game Purchases for Web Developers12.6.2025 20:00:00 EEST | Press release
Xsolla, a leading global video game commerce company, announces a new strategic partnership with Defold, the cross-platform game engine trusted by professionals and indie developers worldwide. This collaboration introduces a seamless integration between Xsolla and Defold-built web games on CrazyGames, enabling developers to easily monetize their titles just in time for the CrazyGames x Defold Game Jam running June 13–15. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612569206/en/ (Graphic: Xsolla) To address the complexity of in-game monetization, Xsolla and Defold have developed a new SDK that allows Defold developers to implement in-game purchasing functionality without the complex manual API setup required. With Xsolla’s sponsorship and support, this integration removes friction from the monetization journey, allowing developers to focus on building engaging games, not commerce infrastructure. This SDK connects three
Pioneering Cancer Plasticity Atlas will Help Predict Response to Cancer Therapies12.6.2025 18:00:00 EEST | Press release
The Wellcome Sanger Institute, Parse Biosciences, and the Computational Health Center at Helmholtz Munich today announced a collaboration to build the foundation of a single cell atlas, focused on understanding and elucidating cancer plasticity in response to therapies. The collaboration will catalyze an ambitious future phase to develop a cancer plasticity atlas encompassing hundreds of millions of cells. Utilizing novel organoid perturbation and Artificial Intelligence (AI) platforms, the aim is to create a comprehensive dataset to fuel foundational drug discovery models and cancer research. Dr. Mathew Garnett, Group Leader at the Sanger Institute, and Prof. Fabian Theis, Director of the Computational Health Center at Helmholtz Munich and Associate Faculty at the Sanger Institute, will be the principal investigators in the collaboration. Garnett’s research team has generated novel 3D organoid cultures that serve as highly scalable and functional cancer models with the ability to capt
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom